Table 1.
First Author (Year) | Sample Size (n) | Male (n) | Female (n) | Mean/Median Age (Years) | Severe Patients (n) % | Symptoms | ||||
---|---|---|---|---|---|---|---|---|---|---|
Fever (%) | Cough (%) | Fatigue (%) | Dyspnoea (%) | Myalgia (%) | ||||||
Xu et al26 | 62 | 35 | 27 | 41 | NR | 77.42 | 80.65 | 51.61 | NR | 51.61 |
Guan et al 23 | 1099 | 640 | 459 | 47 | 173 (16%) | 43.04 | 67.79 | 38.13 | NR | NR |
Guan WJ et al22 | 1590 | 904 | 686 | 49 | 254 (16%) | 84.97 | 66.16 | 36.73 | NR | NR |
Huang et al 6 | 41 | 30 | 11 | 49 | 13 (31%) | 97.56 | 75.61 | 43.90 | 53.66 | 43.90 |
Guo et al27 | 187 | 91 | 96 | 58.50 | NR | NR | NR | NR | NR | NR |
Zhou et al28 | 191 | 119 | 72 | 56 | 66 (34.55) | 94.24 | 79.06 | 23.04 | NR | 15.18 |
Zhang et al 25 | 140 | 71 | 69 | 57 | 58 (41%) | 78.57 | 64.29 | 64.29 | NR | NR |
Liu et al29 | 137 | 61 | 76 | 57 | NR | 81.75 | 48.18 | 32.12 | 18.98 | 32.12 |
Wang et al 8 | 138 | 75 | 63 | 56 | 36 (26%) | 98.55 | 59.42 | 69.57 | 31.16 | 34.78 |
Chen TL et al30 | 203 | 108 | 95 | 54 | 19 (9.36) | 89.16 | 60.10 | 7.88 | 1.48 | 26.60 |
Liu J et al 24 | 61 | 31 | 30 | 40 | 17 (28%) | 98.36 | 63.93 | 57.38 | 4.92 | NR |
Chen et al.21 | 99 | 67 | 32 | 55.5 | NR | 82.83 | 81.82 | NR | NR | NR |
Yang et al31 | 52 | 35 | 17 | 59.7 | 52 (100.00) | 98.08 | 28.85 | NR | 23.08 | 3.85 |
Wu C et al32 | 201 | 128 | 73 | 51 | 53 (26.37) | 93.53 | 81.09 | 32.34 | 39.80 | 32.34 |
Jie Li et al33 | 17 | 09 | 8 | 45.1 | NR | 70.59 | 76.47 | 47.06 | NR | 23.53 |
Mo etal34 | 155 | 86 | 69 | 54 | 55 (35.48) | 81.29 | 62.58 | 38.71 | 1.29 | NR |
Rong-Hui et al35 | 179 | 97 | 82 | 57.6 | NR | 98.88 | 81.56 | 39.66 | 49.72 | 18.99 |
Chen et al36 | 274 | 171 | 103 | 62 | 113 (41.24) | 90.88 | 67.52 | 50.00 | NR | 21.90 |
Deng et al37 | 225 | 73 | 152 | 69 | NR | 42.22 | 20.89 | 13.33 | 34.22 | 13.33 |
Wang et al38 | 339 | 166 | 173 | 69 | 65 (19.17) | 91.74 | 52.80 | 39.82 | 40.71 | 4.72 |
Total | 5390 | 2997 | 2393 | - | 974 | - | - | - | - | - |
Overall Prevalence (95% CI) |
88.47
(80.74, 93.35) |
64.65
(58.42, 70.43) |
38.45
(32.52, 44.74) |
23.59
(16.48, 32.58) |
22.46
(16.36, 30.02) |
|||||
I2 (%) | 98 | 94 | 94 | 92 | 91 | |||||
p for heterogeneity | p < 0.01 | p < 0.01 | p < 0.01 | p < 0.01 | P < 0.01 |
Note: Meta-analysis for the prevalence was calculated from binary random-effects model analysis (see, Figure 1 for details).